AMP Sep 15, 2021 Lung Cancer Biomarker Testing Survey Reveals Access Gaps, Attitudes in Community, Academic Practices Premium Feb 23, 2021 AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic Nov 24, 2020 Clinicians Face New Intervention Questions as Clonal Hematopoiesis Mutation Data Evolves Premium Feb 19, 2020 Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing Nov 12, 2019 AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions Premium Sep 23, 2019 Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium Feb 1, 2019 Healthcare Stakeholders Ask CMS Not to Limit Access to NGS Hereditary Cancer Risk Tests Jan 4, 2019 Pathologist Group Asks Medicare to Reconsider Payment for BRCA Genetic Testing CPT Codes Nov 8, 2018 Biocartis Microsatellite Instability Assay Validated by MSKCC, Dartmouth Researchers Premium Nov 5, 2018 Thermo Fisher Liquid Biopsy, Immuno-Oncology Tools Featured in User Reports at AMP Premium Jan 24, 2018 Lung Cancer Molecular Testing Guidelines Updated by CAP, AMP, IASLC Dec 16, 2016 New Guidelines Aim to Standardize Interpretation and Reporting of Somatic Cancer Variants Premium Mar 30, 2015 CAP, AMP Among Groups Jointly Issuing Colorectal Cancer Molecular Testing Draft Recommendations Breaking News Ratio Therapeutics Raises $20M in Series A Financing Guardant Health, AnHeart Tx to Develop Blood- and Tissue-Based CDx for NSCLC Drug Ellipses Pharma Cleared by FDA to Open Phase I/II AML Trial Survey Reveals Changing Genetic Testing Patterns, Persistent Disparities in Precision Oncology Amgen's Lumakras Sales Increased 58 Percent in Q4 2022 Coeptis Therapeutics, University of Pittsburgh Studying SNAP-CAR Therapy in HER2-Positive Cancers
